Nesher Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Nesher Pharmaceuticals's estimated annual revenue is currently $13.7M per year.(i)
  • Nesher Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Nesher Pharmaceuticals has 68 Employees.(i)
  • Nesher Pharmaceuticals grew their employee count by -4% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2591.1M80577%N/AN/A
#2
$13.1M655%N/AN/A
#3
$9.6M48-29%N/AN/A
#4
$12.5M629%N/AN/A
#5
$43.8M2184%N/AN/A
#6
$1.8M1864%N/AN/A
#7
$6.6M33-3%N/AN/A
#8
$11.7M5812%N/AN/A
#9
$1104.4M34340%$97MN/A
#10
$21.3M1067%N/AN/A
Add Company

Nesher Pharmaceuticals (USA) LLC, a generic pharmaceutical manufacturer located in St. Louis, MO, is a subsidiary of Zydus Pharmaceuticals (USA) Inc. Our business is redefining the standards for pharmaceutical performance, shaped by a passion to deliver value through innovation and an unwavering commitment to compliance. We equate business success with an environment in which employees are encouraged to maximize their potential through personal growth and accountability, resulting in outstanding results for both our people and the customers we serve. If you have the drive and desire to reach a higher level in your career as part of a growth-centric team, come join us!

keywords:N/A

N/A

Total Funding

68

Number of Employees

$13.7M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Nesher Pharmaceuticals's People

NameTitleEmail/Phone
1
Payroll & Benefits ManagerReveal Email/Phone
2
QA Coordinator IIIReveal Email/Phone
3
Senior Director, Quality, Regulatory Affairs and DEA ComplianceReveal Email/Phone
4
PresidentReveal Email/Phone
5
Senior Quality Compliance SpecialistReveal Email/Phone
6
Equipment TechnicianReveal Email/Phone
7
Director Proces DevelopmentReveal Email/Phone
8
Scientist-Analytical Research and DevelopmentReveal Email/Phone
9
Manufacturing OperatorReveal Email/Phone
10
Senior Manufacturing OperatorReveal Email/Phone

Nesher Pharmaceuticals News

2022-04-20 - Global Isosorbide Mononitrate Market 2022 Regional Analysis ...

The prominent market leaders in the worldwide market include: Teva; Merck; Nesher Pharmaceuticals; Taj pharmaceutical; AMRI; Intas...

2022-04-19 - Isosorbide Mononitrate Market Share 2022-2030| Key Players ...

Isosorbide Mononitrate Market Share 2022-2030| Key Players – Teva, Merck, Nesher Pharmaceuticals, Taj Pharmaceutical. Market Size And Forecast. New Jersey, USA,...

2022-03-30 - Heritage Global Partners, New Mill Capital, Keith Machinery, and Federal Equipment Company Acquire Two St. Louis Area Pharmaceutical Plants

... and Federal Equipment Company, it has acquired two pharmaceutical plants in Missouri, formerly of Nesher Pharmaceuticals.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.7M760%N/A
#2
$20.5M7621%N/A
#3
$15.3M854%N/A
#4
$25.1M93-10%N/A
#5
$29.9M1037%N/A

Nesher Pharmaceuticals Executives


NameTitle
Vince KaimanPresident
Ruben Ortiz-ArroyoVP General Manager / VP Operations